Rare disease policy, drug approval process
Source-reported fields
Filing overview
- Type
- Registration
- Posted
- Jul 16, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- ENGEL BURNS
- Client
- ANNEXON BIOSCIENCES
- Filing UUID
- 5029516e-06b6-411d-82c0-7eec921323d8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.